{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:18:35Z","timestamp":1762093115082,"version":"build-2065373602"},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.1248\/bpb.b23-00326","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T22:52:08Z","timestamp":1694040728000},"page":"1527-1534","source":"Crossref","is-referenced-by-count":4,"title":["Osmundacetone Alleviates Cerebral Ischemia\u2013Reperfusion Injury in Rats"],"prefix":"10.1248","volume":"46","author":[{"given":"Bowen","family":"Li","sequence":"first","affiliation":[{"name":"Hebei University of Chinese Medicine"},{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Yu","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine"},{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Yang","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center &amp; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zhao YF, Zhang XJ, Chen XY, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment. <i>Int. J. Mol. Med.<\/i>, <b>49<\/b>, 15 (2022).","DOI":"10.3892\/ijmm.2021.5070"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yin P, Wei YF, Wang X, Zhu MQ, Feng JC. Roles of specialized pro-resolving lipid mediators in cerebral ischemia reperfusion injury. <i>Front. Neurol.<\/i>, <b>9<\/b>, 617 (2018).","DOI":"10.3389\/fneur.2018.00617"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chouchani ET, Pell VR, James AM, Work LM, Saeb-Parsy K, Frezza C, Krieg T, Murphy MP. A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury. <i>Cell Metab.<\/i>, <b>23<\/b>, 254\u2013263 (2016).","DOI":"10.1016\/j.cmet.2015.12.009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Chen XM, Chen HS, Xu MJ, Shen JG. Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury. <i>Acta Pharmacol. Sin.<\/i>, <b>34<\/b>, 67\u201377 (2013).","DOI":"10.1038\/aps.2012.82"},{"key":"5","unstructured":"5) Wu BY, Zhang XF. Clinical effect of traditional Chinese medicine compound in the treatment of cerebral ischemic stroke. <i>Chin. J. Gerontol.<\/i>, <b>42<\/b>, 2081\u20132083 (2022)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Oh JK, Hyun SY, Oh HR, Jung JW, Park C, Lee SY, Park JH, Kim SY, Kim KH, Kim YK, Ryu JH. Effects of <i>Anemarrhena asphodeloides<\/i> on focal ischemic brain injury induced by middle cerebral artery occlusion in rats. <i>Biol. Pharm. Bull.<\/i>, <b>30<\/b>, 38\u201343 (2007).","DOI":"10.1248\/bpb.30.38"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Chen YL, Wu X, Zhu J, Yang GA, Tian JY, Zhao Y, Wang YL. Artesunate provides neuroprotection against cerebral ischemia-reperfusion injury <i>via<\/i> the TLR-4\/NF-kappa B pathway in rats. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 350\u2013356 (2021).","DOI":"10.1248\/bpb.b20-00604"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Cai DK, Luo ZX, Su JY, Gan HN, Wang Z, Liu XL, Li SY, Wu JJ, Chen JY, Ma RQ, Huang M, Zhong GP. Exposure-response analysis and mechanism of ginkgolide B\u2019s neuroprotective effect in acute cerebral ischemia\/reperfusion stage in rat. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 409\u2013420 (2022).","DOI":"10.1248\/bpb.b21-00781"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Li M, Zhang XJ, Cui LL, Yang R, Wang LN, Liu LL, Du W. The neuroprotection of oxymatrine in cerebral ischemia\/reperfusion is related to nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant response: role of Nrf2 and hemeoxygenase-1 expression. <i>Biol. Pharm. Bull.<\/i>, <b>34<\/b>, 595\u2013601 (2011).","DOI":"10.1248\/bpb.34.595"},{"key":"10","unstructured":"10) Li BW, Zhang D, Yang L, Wang MY, Zhu XX. Chemical constituents of <i>Osmundae Rhizoma<\/i>. <i>Natural Product Research and Development<\/i>, <b>24<\/b>, 1214\u20131216 (2012)."},{"key":"11","unstructured":"11) Zhang D, Li BW, Yang L, Fu MH, Fang J. Isolation and determination of Osmundacetone in <i>Osmundae Rhizoma<\/i>. <i>Chin. Pharm. J.<\/i>, <b>45<\/b>, 1612\u20131614 (2010)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Trinh TA, Seo YH, Choi S, Lee J, Kang KS. Protective effect of osmundacetone against neurological cell death caused by oxidative glutamate toxicity. <i>Biomolecules<\/i>, <b>11<\/b>, 328 (2021).","DOI":"10.3390\/biom11020328"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zhu XX, Li YJ, Yang L, Zhang D, Chen Y, Kmonickova E, Weng XG, Yang Q, Z\u00eddek Z. Divergent immunomodulatory effects of extracts and phenolic compounds from the fern <i>Osmunda japonica<\/i> Thunb. <i>Chin. J. Integr. Med.<\/i>, <b>19<\/b>, 761\u2013770 (2013).","DOI":"10.1007\/s11655-013-1460-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Li BW, Chen L, Li B, Tian Y, Liu SJ, Dong JX. Chemical constituents, cytotoxic and antioxidant activities of extract from the rhizomes of <i>Osmunda japonica<\/i> Thunb. <i>Nat. Prod. Res.<\/i>, <b>34<\/b>, 847\u2013850 (2020).","DOI":"10.1080\/14786419.2018.1501692"},{"key":"15","unstructured":"15) Han W, Zhang Y, Wei SN, Meng ZJ, Dai JL. The mechanism of nimodipine on acute cerebral ischemia-reperfusion injury in rats. <i>J. Apoplexy Nerv. Dis.<\/i>, <b>30<\/b>, 713\u2013715 (2013)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gao Y, Chu SF, Li JP, Zhang Z, Yan JQ, Wen ZL, Xia CY, Mou Z, Wang ZZ, He WB, Guo XF, Wei GN, Chen NH. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington\u2019s disease. <i>Acta Pharmacol. Sin.<\/i>, <b>36<\/b>, 311\u2013322 (2015).","DOI":"10.1038\/aps.2014.107"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tanaka N, Ikeda Y, Ohta Y, Deguchi K, Tian FF, Shang JW, Matsuura T, Abe K. Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion. <i>Brain Res.<\/i>, <b>1370<\/b>, 246\u2013253 (2011).","DOI":"10.1016\/j.brainres.2010.11.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. <i>Stroke<\/i>, <b>20<\/b>, 84\u201391 (1989).","DOI":"10.1161\/01.STR.20.1.84"},{"key":"19","unstructured":"19) ChPC. <i>Pharmacopoeia of the People\u2019s Republic of China, 2020 edition<\/i>, China Medicine Science and Technology Press, Beijing (2020)."},{"key":"20","unstructured":"20) Cui W. <i>Study on quality control method of Osmundae rhizoma<\/i>, Beijing University of Chinese Medicine (2012)."},{"key":"21","unstructured":"21) Xu N. Optimization of the flash extraction technology for Osmundacetone and rutin from <i>Osmundae Rhizoma<\/i> by orthogonal test. <i>Chin. Pharm.<\/i>, <b>23<\/b>, 954\u2013957 (2020)."},{"key":"22","unstructured":"22) Li JY, Wang ZY, Liu H. Content determination of chemical constituents in Shalianhewei capsules by HPLC. <i>J. Chin. Mater.<\/i>, <b>42<\/b>, 1851\u20131854 (2019)."},{"key":"23","unstructured":"23) Zhang Y, Niu JB, Li FS, Wang J, Liu CM. Determination of Osmundancetone in inonotus obliquus by RP-HPLC. <i>Food. R. &amp; D.<\/i>, <b>41<\/b>, 172\u2013175 (2020)."},{"key":"24","unstructured":"24) Zhao LS, Dong Y, Shen YJ. Optimization of UPLC-QTOF-MS method for element composition analysis and preparation technology of standard decoction of Sanghuang by response surface methodology. <i>Zhejiang J. Tradit. Chin. Med.<\/i>, <b>57<\/b>, 768\u2013771 (2022)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Wu H, Cao YJ, Wang JQ, Liu RH, Sun Y, Zhang CN, Sun YK. Pharmacokinetic and metabolic profiling studies of osmundacetone in rats by UPLC-MS\/MS and UPLC-QE-Orbitrap-HRMS. <i>Biomed. Chromatogr.<\/i>, <b>36<\/b>, e5251 (2022).","DOI":"10.1002\/bmc.5251"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Liu RY, Zhang YC, Li SN, Liu CM, Zhuang SY, Zhou X, Li YJ, Liang JQ. Receptor-ligand affinity-based screening and isolation of water-soluble 5-lipoxygenase inhibitors from Phellinus igniarius. <i>J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, <b>1209<\/b>, 123415 (2022).","DOI":"10.1016\/j.jchromb.2022.123415"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yang Y, He PY, Hou YH, Liu ZC, Zhang XP, Li N. Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine\/glutamate\/\u03b1-KG metabolic axis. <i>Phytomedicine<\/i>, <b>100<\/b>, 154075 (2022).","DOI":"10.1016\/j.phymed.2022.154075"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Liu X, Cui S, Dan C, Li WL, Xie HQ, Li CH, Shi LG. <i>Phellinus baumii<\/i> Polyphenol: a potential therapeutic candidate against lung cancer cells. <i>Int. J. Mol. Sci.<\/i>, <b>23<\/b>, 16141 (2022).","DOI":"10.3390\/ijms232416141"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) B\u00e9ni Z, D\u00e9k\u00e1ny M, S\u00e1rk\u00f6zy A, Kincses A, Spengler G, Papp V, Hohmann J, V\u00e1nyol\u00f3s A. Triterpenes and phenolic compounds from the fungus <i>Fuscoporia torulosa<\/i>: isolation, structure determination and biological activity. <i>Molecules<\/i>, <b>26<\/b>, 1657 (2021).","DOI":"10.3390\/molecules26061657"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Carlson AP, H\u00e4nggi D, Carlso AP, Macdonald RL, Shuttleworth CW. Nimodipine reappraised: an old drug with a future. <i>Curr. Neuropharmacol.<\/i>, <b>18<\/b>, 65\u201382 (2020).","DOI":"10.2174\/1570159X17666190927113021"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sobrado M, Lopez MG, Carceller F, Garcia AG, Roda JM. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase Bcl-2 expression after focal cerebral ischemia. <i>Neuroscience<\/i>, <b>118<\/b>, 107\u2013113 (2003).","DOI":"10.1016\/S0306-4522(02)00912-0"},{"key":"32","unstructured":"32) Liu YY, Peng T, Yao J, Liu YQ. Neuroprotection of natural products based on Keap1\/Nrf2 \/ARE signaling pathway: a review. <i>Chin. J. Exp. Trad. Med. Formulae<\/i>, <b>29<\/b>, 262\u2013273 (2023)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zhou YP, Jiang ZL, Lu HY, Xu ZY, Tong RS, Shi JY, Jia GQ. Recent advances of natural polyphenols activators for Keap1-Nrf2 signaling pathway. <i>Chem. Biodivers.<\/i>, <b>16<\/b>, e1900400 (2019).","DOI":"10.1002\/cbdv.201900400"},{"key":"34","unstructured":"34) Jiang LJ, Zhang SM, Li CW, Tang JY, Che FY, Lu YC. Roles of the Nrf2\/HO-1 pathway in the anti-oxidative stress response to ischemia-reperfusion brain injury in rats. <i>Eur. Rev. Med. Pharmacol. Sci.<\/i>, <b>21<\/b>, 1532\u20131540 (2017)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Guo H, Li MJ, Liu QQ, Guo LL, Ma MM, Wang SX, Yu B, Hu LM. Danhong injection attenuates ischemia\/reperfusion-induced brain damage which is associating with Nrf2 levels <i>in vivo<\/i> and <i>in vitro<\/i>. <i>Neurochem. Res.<\/i>, <b>39<\/b>, 1817\u20131824 (2014).","DOI":"10.1007\/s11064-014-1384-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Liu Y, Zhang L, Liang JJ. Activation of the Nrf2 defense pathway contributes to neuroprotective effects of phloretin on oxidative stress injury after cerebral ischemia\/reperfusion in rats. <i>J. Neurol. Sci.<\/i>, <b>351<\/b>, 88\u201392 (2015).","DOI":"10.1016\/j.jns.2015.02.045"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/11\/46_b23-00326\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:52:43Z","timestamp":1715575963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/11\/46_b23-00326\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00326","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"article-number":"b23-00326"}}